GTR Home > Tests > Alzheimer Disease Type 1


Test order codeHelp: Requisition form

Test name


Alzheimer Disease Type 1 (APP)

Purpose of the test


This is a clinical test intended for Help: Diagnosis, Mutation Confirmation, Pre-symptomatic



1 condition tested. Click Indication tab for more information.


Molecular Genetics
DDeletion/duplication analysis
Multiplex Ligation-dependent Probe Amplification (MLPA)
ESequence analysis of select exons
Bi-directional Sanger Sequence Analysis

Summary of what is tested

1 genes and variants. Click Methodology tab for more information.


Clinical validity


Not provided

Clinical utility


Not provided

How to order


Not provided

Clinical resources

Practice guidelines

  • CCCDTD, 2014
    Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians.
  • EFNS, 2010
    EFNS guidelines for the diagnosis and management of Alzheimer's disease.
  • EFNS, 2010
    EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias.
  • AHRQ, 2010
    Preventing Alzheimer's disease and cognitive decline.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.